Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBP
Aberdeen Group plc reported a 7.53% stake in Corbus Pharmaceuticals Holdings, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 16, 2026
Aberdeen Group plc reported a 7.53% stake in Corbus Pharmaceuticals Holdings, Inc., 1,321,750 shares, as a passive investor on Dec 31, 2025. Filed Jan 16, 2026 (Schedule 13G).
- Stake
- 7.53%
- Shares
- 1,321,750
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Aberdeen Group plc | 7.53% | 1,321,750 |
| abrdn Inc. | 7.53% | 1,321,750 |
Source
Related
- Corbus Pharmaceuticals Holdings, Inc.
- Aberdeen Group plc
- Corbus Pharmaceuticals Holdings, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Sep 30, 2026
- Form 4 · Ben Yong · Sep 15, 2026
- Form 4 · Nicacio Leonardo Viana · Aug 17, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Form 4 · Saxena Nishant C · Aug 12, 2026